Neuronetics Inc (NASDAQ:STIM) has a beta value of 1.87 and has seen 1.77 million shares traded in the last trading session. The company, currently valued at $173.50M, closed the last trade at $4.33 per share which meant it lost -$0.74 on the day or -14.60% during that session. The STIM stock price is -36.72% off its 52-week high price of $5.92 and 87.99% above the 52-week low of $0.52.
The consensus among analysts is that Neuronetics Inc (STIM) is Buy stock at the moment, with a recommendation rating of 1.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Neuronetics Inc (NASDAQ:STIM) trade information
Sporting -14.60% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the STIM stock price touched $4.33 or saw a rise of 26.86%. Year-to-date, Neuronetics Inc shares have moved 168.94%, while the 5-day performance has seen it change 1.64%. Over the past 30 days, the shares of Neuronetics Inc (NASDAQ:STIM) have changed 21.63%.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 45.88% from current levels. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -84.76% off the targeted high while a plunge would see the stock gain -84.76% from current levels.
Neuronetics Inc (STIM) estimates and forecasts
The company’s shares have gained 452.93% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 2.87% over the past 5 years. Earnings growth for 2025 is a modest 77.06% while over the next 5 years, the company’s earnings are expected to increase by 61.20%.
STIM Dividends
Neuronetics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
The top two institutional holders are ARCHON CAPITAL MANAGEMENT LLC with over 2.47 million shares worth more than $4.45 million. As of 2024-06-30, ARCHON CAPITAL MANAGEMENT LLC held 8.23% of shares outstanding.
The other major institutional holder is CANNELL CAPITAL LLC, with the holding of over 2.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $4.29 million and represent 7.9239% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.80% shares in the company for having 849.5 shares of worth $3.68 million while later fund manager owns 403.88 shares of worth $1.75 million as of Dec 31, 2024 , which makes it owner of about 1.33% of company’s outstanding stock.
